全球准药品市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球准药品市场 – 行业趋势及 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Quasi Drugs Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 102.70 Billion
Diagram Market Size (Forecast Year)
USD 163.69 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Pfizer
  • COSMOBEAUTY CO.
  • GL Sciences
  • Japan Cosmetic Agency Tokyo Co.
  • Kindai Kagaku

>全球准药品市场,按类别(第 1 组、第 2 组、第 3 组)、最终用户(医院家庭护理、专科诊所、其他)、分销渠道(医院药房、网上药房、零售药房)划分 – 行业趋势和预测至 2030 年。

准药品市场

医药部外品市场分析及规模

预计在预测期内,准药品市场将出现显著增长。痤疮和暗沉皮肤相关问题的增加推动了准药品市场的发展。由于环境污染的增加以及人们口腔和个人卫生意识的提高,这种意识得到了更广泛的传播。美容产品的使用率在人群中激增,尤其是女性。

Data Bridge Market Research 分析了 2023-2030 年预测期内准药品市场的增长率。在上述预测期内,准药品市场的预期复合年增长率趋于 6% 左右。2022 年市场价值为 1027 亿美元,到 2030 年将增长至 1636.9 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外,Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

准药品市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

组(第 1 组、第 2 组、第 3 组)、最终用户(医院、家庭护理、专科诊所、其他)、分销渠道(医院药房、网上药房、零售药房)

覆盖国家

北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区

涵盖的市场参与者

辉瑞公司(美国)、COSMOBEAUTY 株式会社(日本)、GL Sciences Inc(日本)、日本化妆品代理东京株式会社(日本)、日本现代化学株式会社(日本)、TAE BONG 株式会社(韩国)、国际洗漱用品株式会社(日本)

市场机会

  • 提高个人和口腔卫生意识
  • 零售药店需求不断增长

市场定义

Quasi drugs are one of the two primary categories of beauty products. There is a thin line between drugs and cosmetics, that can be considered as quasi-drugs. South Korea’s health authority (HA), the Ministry of Food and Drug Safety (MFDS) has categorized them under pinpoint skin care products such as acne for skin dullness as their benefits are not as suitable like drugs. Group 1 includes items used for sanitary purposes such as sanitary pads, tampons, menstrual pads, and wet wipes for oral hygiene. Group 2 includes odour inhibitors such as toothpaste, antiperspirants, and bath products, contact lenses.

Global Quasi Drugs Market Dynamics

Drivers

  • Increase in Acne Cases

Acne is the most common skin condition in the U.S., affecting around 50 million people annually. Acne usually begins in puberty and affects several adolescents and young adults. Around 85 % of people between the age group of 12 and 24 years experience at least minor acne. It is also common among adults because of increasing stress, pollution, hormonal imbalance, and among others. This factor contributes in the market growth.

Opportunities

  • Rising Awareness about Personal and oral Hygiene

People are getting more and more aware of personal and oral hygiene. Good personal hygiene is essential for both health and social reasons. The social benefits associated with personal habits need to be considered. In terms of oral hygiene, caring for the teeth and practicing good oral hygiene wards off bad breath, tooth decay, gum disease, and many infections. Thus, it demands a lot of quasi drugs, which helps in the growth of the market expansion.

  • Increasing Demand for Retail Pharmacies

The increase in the number of quasi drugs delivered through retail pharmacies and the rise in the number of retail pharmacies in vastly developed countries create opportunities for the market growth. Furthermore, patients choose retail pharmacies for purchasing drugs, as these are easily available.

 Restraints/Challenges

  • Limited Studies and Surveys

Very limited studies and surveys are associated with the quasi drug application, hindering the market's growth. Only an insignificant amount of data are available with respect to the studies. A few studies mainly focused on groups from a single hospital wherein only a limited number of patients are observed. Thus, this hampers the growth of the market.

This quasi drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the quasi drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Quasi Drugs Market Scope

The quasi drugs market is segmented on the basis of group, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Group

  • Group 1
  • Group 2
  • Group 3

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Quasi Drugs Market Regional Analysis/Insights

The quasi drugs market is analyzed and market size insights and trends are provided by group, distribution channel and end-user as referenced above.

The major countries covered in the quasi drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for quasi drugs market due to increased healthcare and R&D expenditure and the presence of skilled professionals.

Asia-Pacific dominates the market because of the increased general skin problems, increased awareness for quasi drugs through advertisement, and rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Quasi Drugs Market Share Analysis

准药品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对准药品市场的关注有关

准药品市场的主要参与者包括:

  • 辉瑞公司(美国)
  • COSMOBEAUTY 株式会社(日本)
  • GL Sciences Inc(日本)。
  • 日本化妆品代理东京有限公司(日本)
  • 近代科学(日本)
  • TAE BONG CO., LTD (韩国)
  • 国际盥洗用品有限公司 (日本)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Group (Group 1, Group 2, Group 3), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030. .
The Global Quasi Drugs Market size was valued at USD 102.70 USD Billion in 2022.
The Global Quasi Drugs Market is projected to grow at a CAGR of 6% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer , COSMOBEAUTY CO., GL Sciences , Japan Cosmetic Agency Tokyo Co., Kindai Kagaku, TAE BONG CO., International Toiletries Co.,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.